Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in nonchemotherapy-pretreated patients

Ronald de Wit, Wim Kruit, Gerrit Stoter, M Boer-Dennert, J Kerger, Jaap Verweij

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1342-1345
Number of pages4
JournalBritish Journal of Cancer
Volume78
Issue number10
Publication statusPublished - 1998

Cite this